Clinical trials
Recruiting Phase 1/2 Leukemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 7 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Princess Maxima Center for Pediatric Oncology | 3 |
| AVM Biotechnology Inc | 1 |
| AstraZeneca | 1 |
| AvenCell Therapeutics, Inc. | 1 |
| Children's Hospital of Philadelphia | 1 |
| Dren Bio | 1 |
| Essen Biotech | 1 |
| Incyte Biosciences International Sàrl | 1 |
| Inhye Ahn | 1 |
| Jacqueline Garcia, MD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 19 |
| Lymphoma | 8 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Recurrence | 5 |
| Leukemia, Biphenotypic, Acute | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 |
| Leukemia, Myeloid, Acute | 4 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.